27
Participants
Start Date
Not specified
Study Completion Date
February 28, 1999
Vinblastine sulfate
Dacarbazine
Filgrastim
Bleomycin sulfate
Doxorubicin hydrochloride
Alabama Therapeutics CRS, Birmingham
Northwestern University CRS, Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
The Ohio State Univ. AIDS CRS, Columbus
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
USC CRS, Los Angeles
Washington U CRS, St Louis
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Collaborators (1)
Amgen
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH